Related Experiment Video
Updated: Aug 20, 2026

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints
Published on: December 9, 2025
Complement C5a is a key mediator of meconium-induced neutrophil activation
Albert Castellheim1, Anne Pharo, Michael Fung
1Department of Pediatric Research, Rikshospitalet University Hospital, 0027 Oslo, Norway. albert.castellheim@klinmed.uio.no
Abstract:
Meconium aspiration syndrome is a serious condition of the newborn characterized by pulmonary inflammation with substantial neutrophil infiltration. We recently showed that meconium is a potent activator of complement. The aim of the present study was to investigate a possible role for complement in meconium-induced neutrophil activation. Meconium was incubated in human whole blood anticoagulated with lepirudin, a specific thrombin inhibitor that does not affect complement activation. Complement activation was detected by measuring the terminal complement complex. Neutrophil oxidative burst and changes in CD11b and L-selectin expression were measured by flow cytometry. Complement was inhibited using the MAb 166-32 and 137-26, which block factor D and neutralize C5a, respectively. Meconium markedly activated the neutrophils, as revealed by up-regulation of CD11b, accentuation of L-selectin shedding, and induction of oxidative burst. Complement inhibition using the anti-factor D antibody completely (95-100%) blocked meconium-induced changes in CD11b and L-selectin expression, whereas oxidative burst was reduced by 60-70%. The anti-C5a antibody inhibited the neutrophil activation to the same extent as anti-factor D. The data suggest that complement activation is largely responsible for the neutrophil inflammatory responses induced by meconium in vitro and that C5a is a key mediator of this response.
Insights
Meconium strongly activates neutrophils, a key part of newborn inflammation. Complement activation, particularly C5a, drives this response, offering potential therapeutic targets for meconium aspiration syndrome.
Area of Science:
- Neonatal immunology
- Complement system biology
- Inflammatory response mechanisms
Background:
- Meconium aspiration syndrome (MAS) involves severe newborn lung inflammation with neutrophil infiltration.
- Meconium is a known potent activator of the complement system.
- The specific role of complement in meconium-induced neutrophil activation requires further investigation.
Purpose of the Study:
- To investigate the role of the complement system in mediating neutrophil activation by meconium.
- To identify key complement components involved in the inflammatory response to meconium.
Main Methods:
- Incubation of meconium in human whole blood with complement activation.
- Measurement of complement activation via terminal complement complex detection.
- Assessment of neutrophil activation (oxidative burst, CD11b and L-selectin expression) using flow cytometry.
- Inhibition of complement activation using specific monoclonal antibodies against Factor D and C5a.
Main Results:
- Meconium induced significant neutrophil activation, including CD11b up-regulation, L-selectin shedding, and oxidative burst.
- Inhibition of Factor D completely blocked CD11b and L-selectin changes and reduced oxidative burst by 60-70%.
- Neutralization of C5a demonstrated similar inhibitory effects on neutrophil activation as Factor D inhibition.
- Complement activation is largely responsible for meconium-induced neutrophil inflammatory responses in vitro.
Conclusions:
- Complement activation plays a critical role in meconium-induced neutrophil inflammation in newborns.
- C5a is identified as a key mediator in the complement-driven inflammatory response to meconium.
- Targeting the complement system, specifically C5a, may offer therapeutic strategies for MAS.
Related Concept Videos
Complement System
Inflammation
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Differentiation of Common Myeloid Progenitor Cells
Acute Inflammation II: Cellular Phase
Acute Inflammation I: Inflammatory Response
